drugset / Trial / NCT01515384
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to evaluate the safety and pancreas imaging properties of 18F-AV-133.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DTBZ | Diagnostic / imaging agent | 281.2 mbq | Intravenous |